Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
GEN Roundup on Bioprocess Filtration
From our February 15 issue: Trends and tips to improve processes are featured in this GEN roundtable with bioprocessing experts.
- Mr. Bromm: Filter manufacturers particularly have improved the performance of sterilizing-grade and virus retentive filters. Users’ willingness to collaborate and share the composition of solutions to be filtered has helped vendors better understand blocking mechanisms and design new high-performance filters. Highly asymmetric polyethersulfone (PES) membranes, which ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.